Correction: Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle

Present: Due to an error made during the manuscript revision process, a notice designating Drs. Rosanna Piccirillo and Raffaella Giavazzi as joint last authors has been omitted.

Corrected: Correct author list is provided below. Authors sincerely apologize for this oversight.

Original article: Oncotarget. 2015; 6(5): 3043-54. doi: 10.18632/oncotarget.2812.

Francesca Pretto^1,4,*, Carmen Ghilardi^1,*, Michele Moschetta¹, Andrea Bassi², Alessandra Rovida¹, Valentina Scarlato¹, Laura Talamini¹, Fabio Fiordaliso³, Cinzia Bisighini³, Giovanna Damia¹, Maria Rosa Bani¹, Rosanna Piccirillo^1,** and Raffaella Giavazzi^1,**

¹ Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche “Mario Negri”, 20156 Milan, Italy

² Department of Phisics, Politecnico di Milano, 20133 Milan, Italy

³ Department of Cardiovascular Research, IRCCS-Istituto di Ricerche Farmacologiche “Mario Negri”, 20156 Milan, Italy

⁴ Present address: Philochem AG, 8112 Otelfingen, Switzerland

^* These authors have contributed equally to this work

^** Joint last authors